ALHC Earnings

ALHC reported its earnings on 2026-02-26, showcasing a revenue of against an estimate of 1000.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected -0.15 by 0%. The stock experienced a -5.88% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following ALHC's earnings announcement on 2026-02-26, the stock price moved by -5.88% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, ALHC's stock price tends to shift by an average of 3.23% in the 10 days leading up to earnings and 3.54% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate ALHC's annual revenue to reach 1.20B, while the EPS is projected at 0.11. These estimates reflect recent revisions, with revenue estimates revised upward by 0.09% and EPS estimates revised upward by 0.27% over the past three months, indicating analyst expectation in the company's performance.

The correlation between ALHC's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were revised upward by 0.09%, while EPS estimates moved revised upward by 0.27%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ALHC's stock price typically moves by 3.23% in the 10 days before its earnings and 3.54% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 0.11 and revenue of 1.20B.

The earnings call summary and Q&A indicate strong financial performance with increased EBITDA and revenue, positive free cash flow, and improved operational efficiency. While SG&A increased, it declined as a percentage of revenue. Optimistic guidance and strategic market positioning, including AI investments and strong provider relationships, further support a positive outlook. The company's low exposure to risk model rebasing and proactive approach to regulatory changes enhance confidence. The market cap suggests moderate sensitivity to these positive developments, leading to a likely positive stock price movement over the next two weeks.